Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.
Clinical trial NCT02371174 · COMPLETED
Trial details
- NCT number
- NCT02371174
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-09-03
- Primary completion
- 2018-01-21
- Enrollment
- 651
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.